about
Mechanisms of fibrin polymerization and clinical implicationsWrecked regulation of intrinsically disordered proteins in diseases: pathogenicity of deregulated regulatorsViscoelasticity as a measurement of clot structure in poorly controlled type 2 diabetes patients: towards a precision and personalized medicine approachPoststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain strokeProcoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.Increased Oxidation as an Additional Mechanism Underlying Reduced Clot Permeability and Impaired Fibrinolysis in Type 2 Diabetes.Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis.Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid.The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen).Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.Weight reduction is associated with increased plasma fibrin clot lysis.Impact of homocysteine-thiolactone on plasma fibrin networks.Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction.New findings on venous thrombogenesis.Fibrinogen and Fibrin in Hemostasis and Thrombosis.Intrinsic Disorder and Posttranslational Modifications: The Darker Side of the Biological Dark Matter.Fibrinogen and factor XIII: newly recognized roles in venous thrombus formation and composition
P2860
Q26865281-A650DF3A-54AE-4365-AE57-57266532ECB1Q27000495-F23DCE44-11C4-4FD9-81C2-1D17FA101D82Q30390876-D908D305-B959-40F8-A9E0-8302DF6B071DQ35207266-DD989952-3B16-4205-A3D3-9C8EDE03D813Q35690807-07793B4B-F603-4253-899A-AA76921DFBE1Q36015232-67F2A582-9AFE-4FBC-9106-8D8A0F01D244Q36925296-7E8C1585-C6D6-409D-8B4E-44E45CB12C12Q37326771-C4A81315-AB65-4968-9487-0916307470D6Q38248477-C518DB5F-53EB-4F2E-8157-93771AE589C0Q38261764-FB59577C-72CD-4714-9870-1463B3C30ED5Q42332549-80BF3058-C0DB-4DD4-902E-99A3D41C18F8Q46769026-9FB23B1D-29FD-4832-8321-D913E9E118E7Q46915515-D49080C1-2D5E-40BA-A17D-87E4140AD634Q47596958-DDD10A6E-0D52-4A87-A1F0-BE6784AB60F1Q47938011-DD52304E-D6DE-439F-9745-D77E5172D7A1Q54842287-F79C5011-D410-4241-BB1C-B8C3029F151CQ55066708-C3FEDBA8-092F-4805-9F6D-D9046BFD0B2AQ58770454-58295206-1FE2-4490-A205-0F73FD6F6993
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alterations of fibrinogen structure in human disease.
@en
Alterations of fibrinogen structure in human disease.
@nl
type
label
Alterations of fibrinogen structure in human disease.
@en
Alterations of fibrinogen structure in human disease.
@nl
prefLabel
Alterations of fibrinogen structure in human disease.
@en
Alterations of fibrinogen structure in human disease.
@nl
P1476
Alterations of fibrinogen structure in human disease.
@en
P2093
P304
P356
10.2174/187152508784871981
P577
2008-07-01T00:00:00Z